194 related articles for article (PubMed ID: 16732297)
1. Permeability properties of tumor surrogate blood vessels induced by VEGF-A.
Nagy JA; Feng D; Vasile E; Wong WH; Shih SC; Dvorak AM; Dvorak HF
Lab Invest; 2006 Aug; 86(8):767-80. PubMed ID: 16732297
[TBL] [Abstract][Full Text] [Related]
2. Vesiculo-vacuolar organelles and the regulation of venule permeability to macromolecules by vascular permeability factor, histamine, and serotonin.
Feng D; Nagy JA; Hipp J; Dvorak HF; Dvorak AM
J Exp Med; 1996 May; 183(5):1981-6. PubMed ID: 8642308
[TBL] [Abstract][Full Text] [Related]
3. Different pathways of macromolecule extravasation from hyperpermeable tumor vessels.
Feng D; Nagy JA; Dvorak AM; Dvorak HF
Microvasc Res; 2000 Jan; 59(1):24-37. PubMed ID: 10625568
[TBL] [Abstract][Full Text] [Related]
4. Pathways of macromolecular tracer transport across venules and small veins. Structural basis for the hyperpermeability of tumor blood vessels.
Kohn S; Nagy JA; Dvorak HF; Dvorak AM
Lab Invest; 1992 Nov; 67(5):596-607. PubMed ID: 1279271
[TBL] [Abstract][Full Text] [Related]
5. Ultrastructural localization of the vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) receptor-2 (FLK-1, KDR) in normal mouse kidney and in the hyperpermeable vessels induced by VPF/VEGF-expressing tumors and adenoviral vectors.
Feng D; Nagy JA; Brekken RA; Pettersson A; Manseau EJ; Pyne K; Mulligan R; Thorpe PE; Dvorak HF; Dvorak AM
J Histochem Cytochem; 2000 Apr; 48(4):545-56. PubMed ID: 10727296
[TBL] [Abstract][Full Text] [Related]
6. Distribution of vascular permeability factor (vascular endothelial growth factor) in tumors: concentration in tumor blood vessels.
Dvorak HF; Sioussat TM; Brown LF; Berse B; Nagy JA; Sotrel A; Manseau EJ; Van de Water L; Senger DR
J Exp Med; 1991 Nov; 174(5):1275-8. PubMed ID: 1940805
[TBL] [Abstract][Full Text] [Related]
7. Ultrastructural localization of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) to the abluminal plasma membrane and vesiculovacuolar organelles of tumor microvascular endothelium.
Qu-Hong ; Nagy JA; Senger DR; Dvorak HF; Dvorak AM
J Histochem Cytochem; 1995 Apr; 43(4):381-9. PubMed ID: 7534783
[TBL] [Abstract][Full Text] [Related]
8. The vesiculo-vacuolar organelle (VVO): a distinct endothelial cell structure that provides a transcellular pathway for macromolecular extravasation.
Dvorak AM; Kohn S; Morgan ES; Fox P; Nagy JA; Dvorak HF
J Leukoc Biol; 1996 Jan; 59(1):100-15. PubMed ID: 8558058
[TBL] [Abstract][Full Text] [Related]
9. Pathways of macromolecular extravasation across microvascular endothelium in response to VPF/VEGF and other vasoactive mediators.
Feng D; Nagy JA; Pyne K; Hammel I; Dvorak HF; Dvorak AM
Microcirculation; 1999 Mar; 6(1):23-44. PubMed ID: 10100187
[TBL] [Abstract][Full Text] [Related]
10. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis.
Dvorak HF; Brown LF; Detmar M; Dvorak AM
Am J Pathol; 1995 May; 146(5):1029-39. PubMed ID: 7538264
[TBL] [Abstract][Full Text] [Related]
11. Glomeruloid microvascular proliferation follows adenoviral vascular permeability factor/vascular endothelial growth factor-164 gene delivery.
Sundberg C; Nagy JA; Brown LF; Feng D; Eckelhoefer IA; Manseau EJ; Dvorak AM; Dvorak HF
Am J Pathol; 2001 Mar; 158(3):1145-60. PubMed ID: 11238063
[TBL] [Abstract][Full Text] [Related]
12. Early Actions of Anti-Vascular Endothelial Growth Factor/Vascular Endothelial Growth Factor Receptor Drugs on Angiogenic Blood Vessels.
Sitohy B; Chang S; Sciuto TE; Masse E; Shen M; Kang PM; Jaminet SC; Benjamin LE; Bhatt RS; Dvorak AM; Nagy JA; Dvorak HF
Am J Pathol; 2017 Oct; 187(10):2337-2347. PubMed ID: 28736316
[TBL] [Abstract][Full Text] [Related]
13. Caveolae and vesiculo-vacuolar organelles in bovine capillary endothelial cells cultured with VPF/VEGF on floating Matrigel-collagen gels.
Vasile E; Qu-Hong ; Dvorak HF; Dvorak AM
J Histochem Cytochem; 1999 Feb; 47(2):159-67. PubMed ID: 9889252
[TBL] [Abstract][Full Text] [Related]
14. Vascular permeability factor/vascular endothelial growth factor: a multifunctional angiogenic cytokine.
Brown LF; Detmar M; Claffey K; Nagy JA; Feng D; Dvorak AM; Dvorak HF
EXS; 1997; 79():233-69. PubMed ID: 9002222
[TBL] [Abstract][Full Text] [Related]
15. Chapter 3. The adenoviral vector angiogenesis/lymphangiogenesis assay.
Nagy JA; Shih SC; Wong WH; Dvorak AM; Dvorak HF
Methods Enzymol; 2008; 444():43-64. PubMed ID: 19007660
[TBL] [Abstract][Full Text] [Related]
16. Heterogeneity of the tumor vasculature: the need for new tumor blood vessel type-specific targets.
Nagy JA; Dvorak HF
Clin Exp Metastasis; 2012 Oct; 29(7):657-62. PubMed ID: 22692562
[TBL] [Abstract][Full Text] [Related]
17. Heterogeneity of the angiogenic response induced in different normal adult tissues by vascular permeability factor/vascular endothelial growth factor.
Pettersson A; Nagy JA; Brown LF; Sundberg C; Morgan E; Jungles S; Carter R; Krieger JE; Manseau EJ; Harvey VS; Eckelhoefer IA; Feng D; Dvorak AM; Mulligan RC; Dvorak HF
Lab Invest; 2000 Jan; 80(1):99-115. PubMed ID: 10653008
[TBL] [Abstract][Full Text] [Related]
18. Tumor-surrogate blood vessel subtypes exhibit differential susceptibility to anti-VEGF therapy.
Sitohy B; Nagy JA; Jaminet SC; Dvorak HF
Cancer Res; 2011 Nov; 71(22):7021-8. PubMed ID: 21937680
[TBL] [Abstract][Full Text] [Related]
19. Vascular permeability and pathological angiogenesis in caveolin-1-null mice.
Chang SH; Feng D; Nagy JA; Sciuto TE; Dvorak AM; Dvorak HF
Am J Pathol; 2009 Oct; 175(4):1768-76. PubMed ID: 19729487
[TBL] [Abstract][Full Text] [Related]
20. Time-dependent vascular regression and permeability changes in established human tumor xenografts induced by an anti-vascular endothelial growth factor/vascular permeability factor antibody.
Yuan F; Chen Y; Dellian M; Safabakhsh N; Ferrara N; Jain RK
Proc Natl Acad Sci U S A; 1996 Dec; 93(25):14765-70. PubMed ID: 8962129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
